ACROBiosystems Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Human IgG1 (AS35)
Supplier: ACROBiosystems SADS35100UG
Antibody;100UG;Human IgG1/kappa;This product is a specific antibody against SARS-CoV-2 Spike protein RBD domain. No cross-reactivity is deteced with Spike protein RBD domain of other coronaviruses, including SARS-CoV, MERS-CoV, HCoV-229E, HCoV-NL63, HCoV-OC43 and HCoV-HKU1.;Anti-SARS-CoV-2 RBD Neutralizing Antibody, Human IgG1 (SAD-S35) is isolated from a SARS-CoV-2 infected patient and is recombinantly produced from human 293 cells (HEK293). This antibody recognizes the SARS-CoV-2 Spike Protein RBD domain and inhibits the interaction between SARS-CoV-2 RBD and ACE2 with an IC50 of 1.47 μg/mL using SARS-CoV-2 Inhibitor Screening Kit (Cat. No. EP-105).Pseudovirus assay shows that this antibody has potent neutralizing activity against pseudovirus bearing SARS-CoV-2 Spike protein.;This protein . The protein migrates as 27 kDa and 55 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.;Serial dilutions of Anti-SARS-CoV-2 RBD Neutralizing Antibody, Human IgG
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok